article thumbnail

Medicare to cover Novo’s obesity drug for some patients

Healthcare Dive

Two weeks after the FDA updated Wegovy’s label, Medicare changed its stance to allow people with a history of heart disease to receive treatment, a shift that could further boost access to the fast-selling medicine.

Medicare 286
article thumbnail

Cigna is still interested in Medicare

Healthcare Dive

The health insurer sees Medicare Advantage as an area for future growth, despite selling the division for $3.7 billion earlier this week. Cigna’s CEO called the sale a “win-win” on a call with investors Friday.

Medicare 278
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MA spending to outstrip traditional Medicare by $88B this year: MedPAC

Healthcare Dive

MedPAC released the data Friday during a contentious meeting where members argued over the efficacy of Medicare Advantage.

Medicare 337
article thumbnail

Humana sues HHS over Medicare Advantage audits

Healthcare Dive

The payer, which brings in the bulk of its revenue from Medicare, is fighting back against a rule finalized earlier this year to claw back overpayments in the increasingly popular MA program.

Medicare 294
article thumbnail

CMS to get ‘tougher’ on Medicare Advantage, official promises

Healthcare Dive

CMS Deputy Administrator Jon Blum signaled regulators could increasingly crack down on bad actors in the MA program, which now covers more than half of Medicare seniors.

Medicare 317
article thumbnail

Lobby-funded study argues Medicare Advantage rate cuts are worse than CMS expects

Healthcare Dive

Medicare Advantage payment per month, per beneficiary could drop by 1% next year if regulators finalize rates as proposed, according to the analysis backed by the Better Medicare Alliance.

Medicare 269
article thumbnail

Medicare go-broke date pushed back to 2031

Healthcare Dive

The date Medicare’s hospital trust fund is expected to run dry has been extended by three years, but stakeholders continue to urge action from Washington to address Medicare’s long-term solvency.

Medicare 312